Los Angeles Capital Management LLC / HALO
Los Angeles Capital Management LLC’s Halozyme Therapeutics Inc Position
Does Los Angeles Capital Management LLC own Halozyme Therapeutics Inc (HALO)? Yes — 689.9K shares worth $45M (+0.18% of its 13F portfolio) as of Q1 2026, down from 1.10M shares the prior filed quarter.
Position Value
$45M
Q1 2026
Shares
689.9K
% of Portfolio
+0.18%
Quarters Held
30
currently held
Position History HALO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 689.9K | $45M | +0.18% |
| Q4 2025 | 1.10M | $71M | +0.24% |
| Q3 2025 | 1.08M | $79M | +0.27% |
| Q2 2025 | 973.7K | $51M | +0.19% |
| Q1 2025 | 92.6K | $6M | +0.03% |
| Q4 2024 | 92.5K | $4M | +0.02% |
| Q3 2024 | 110.6K | $6M | +0.03% |
| Q2 2024 | 116.3K | $6M | +0.02% |
| Q1 2024 | 121.0K | $5M | +0.02% |
| Q4 2023 | 103.3K | $4M | +0.01% |
| Q3 2023 | 101.3K | $4M | +0.02% |
| Q2 2023 | 91.5K | $3M | +0.01% |
| Q1 2023 | 73.1K | $3M | +0.01% |
| Q4 2022 | 152.4K | $9M | +0.04% |
| Q3 2022 | 181.2K | $7M | +0.04% |
| Q2 2022 | 195.6K | $9M | +0.04% |
| Q1 2022 | 193.9K | $8M | +0.03% |
| Q4 2021 | 193.9K | $8M | +0.03% |
| Q3 2021 | 69.0K | $3M | +0.01% |
| Q2 2021 | 54.4K | $2M | +0.01% |
| Q1 2021 | 69.4K | $3M | +0.01% |
| Q4 2020 | 113.7K | $5M | +0.02% |
| Q3 2020 | 111.9K | $3M | +0.01% |
| Q2 2020 | 143.5K | $4M | +0.02% |
| Q1 2020 | 142.0K | $3M | +0.02% |
| Q4 2019 | 75.8K | $1M | +0.01% |
| Q3 2019 | 151.0K | $2M | +0.01% |
| Q2 2019 | 210.3K | $4M | +0.02% |
| Q1 2019 | 272.3K | $4M | +0.02% |
| Q4 2018 | 275.4K | $4M | +0.02% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Los Angeles Capital Management LLC’s full portfolio or all institutional holders of HALO.